Becton, Dickinson and Company (BDX)’s Stock Insider Selling – Alexandre Conroy Sold 20,128 Shares; Jericho Capital Asset Management LP Has Lifted By $77.02 Million Its New Oriental Ed & Tech Grp I (EDU) Holding

Becton, Dickinson and Company (NYSE:BDX) Logo

Jericho Capital Asset Management Lp increased New Oriental Ed & Tech Grp I (EDU) stake by 245.74% reported in 2017Q4 SEC filing. Jericho Capital Asset Management Lp acquired 828,128 shares as New Oriental Ed & Tech Grp I (EDU)’s stock declined 4.38%. The Jericho Capital Asset Management Lp holds 1.17 million shares with $109.52M value, up from 337,000 last quarter. New Oriental Ed & Tech Grp I now has $16.02 billion valuation. The stock increased 5.02% or $4.84 during the last trading session, reaching $101.33. About 2.17M shares traded or 45.20% up from the average. New Oriental Education & Technology Group Inc. (NYSE:EDU) has risen 50.87% since May 24, 2017 and is uptrending. It has outperformed by 39.32% the S&P500.

Becton, Dickinson and Company (NYSE:BDX) Ratings Coverage

Among 20 analysts covering Becton Dickinson (NYSE:BDX), 13 have Buy rating, 0 Sell and 7 Hold. Therefore 65% are positive. Becton Dickinson has $260.0 highest and $146 lowest target. $230.79’s average target is 2.01% above currents $226.25 stock price. Becton Dickinson had 53 analyst reports since August 7, 2015 according to SRatingsIntel. As per Thursday, August 3, the company rating was maintained by RBC Capital Markets. The firm earned “Buy” rating on Wednesday, August 19 by Argus Research. Stifel Nicolaus maintained the stock with “Buy” rating in Thursday, August 3 report. Jefferies maintained Becton, Dickinson and Company (NYSE:BDX) rating on Tuesday, February 6. Jefferies has “Buy” rating and $260.0 target. RBC Capital Markets maintained the stock with “Hold” rating in Thursday, February 8 report. The rating was downgraded by Morgan Stanley to “Equal-Weight” on Monday, January 4. The rating was maintained by Jefferies on Thursday, March 30 with “Buy”. The firm has “Buy” rating given on Wednesday, September 27 by Cowen & Co. Cowen & Co maintained the stock with “Buy” rating in Monday, July 10 report. The rating was initiated by Citigroup with “Neutral” on Thursday, November 12.

Investors sentiment increased to 1.55 in Q4 2017. Its up 0.62, from 0.93 in 2017Q3. It increased, as 50 investors sold Becton, Dickinson and Company shares while 294 reduced holdings. 147 funds opened positions while 386 raised stakes. 215.77 million shares or 9.23% more from 197.53 million shares in 2017Q3 were reported. Great Lakes Advsrs Lc holds 15,833 shares or 0.07% of its portfolio. Valley Natl Advisers invested in 0.51% or 6,909 shares. Moreover, Earnest Ptnrs Ltd Com has 0.25% invested in Becton, Dickinson and Company (NYSE:BDX) for 123,584 shares. Campbell Newman Asset Management has invested 2.73% in Becton, Dickinson and Company (NYSE:BDX). Amica Pension Fund Board Of Trustees reported 3,164 shares. D L Carlson Inv invested in 24,419 shares. 4,695 are owned by Orrstown. Cohen Lawrence B holds 4,272 shares or 0.58% of its portfolio. Arrow Finance Corp has invested 0.02% of its portfolio in Becton, Dickinson and Company (NYSE:BDX). Spinnaker Trust reported 0.12% in Becton, Dickinson and Company (NYSE:BDX). Sandy Spring Retail Bank has 0.11% invested in Becton, Dickinson and Company (NYSE:BDX). Nuance Investments Ltd Liability Co accumulated 191,372 shares or 2.74% of the stock. Moreover, Ent Fincl Services has 0.02% invested in Becton, Dickinson and Company (NYSE:BDX) for 162 shares. Inv Limited Oh Adv holds 1,673 shares. Court Place Advsr Limited Co holds 1,163 shares or 0.1% of its portfolio.

Becton, Dickinson and Company develops, makes, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company has market cap of $60.45 billion. It operates in two divisions, BD Medical and BD Life Sciences. It has a 175.66 P/E ratio. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems.

The stock increased 0.31% or $0.71 during the last trading session, reaching $226.25. About 1.42 million shares traded or 19.20% up from the average. Becton, Dickinson and Company (NYSE:BDX) has risen 15.92% since May 24, 2017 and is uptrending. It has outperformed by 4.37% the S&P500.

Since February 23, 2018, it had 1 insider buy, and 6 insider sales for $9.39 million activity. On Monday, May 21 Conroy Alexandre sold $4.60 million worth of Becton, Dickinson and Company (NYSE:BDX) or 20,128 shares. Shabshab Nabil sold 10,209 shares worth $2.31 million. The insider Gallagher John E sold $1.21 million. Another trade for 500 shares valued at $112,535 was made by Melcher David F on Monday, May 7. $38,416 worth of stock was sold by RING TIMOTHY M on Friday, February 23. Borzi James W sold $910,726 worth of stock. Shares for $426,079 were sold by Polen Thomas E Jr on Tuesday, March 13.

Analysts await Becton, Dickinson and Company (NYSE:BDX) to report earnings on August, 2. They expect $2.84 earnings per share, up 15.45% or $0.38 from last year’s $2.46 per share. BDX’s profit will be $758.85M for 19.92 P/E if the $2.84 EPS becomes a reality. After $2.65 actual earnings per share reported by Becton, Dickinson and Company for the previous quarter, Wall Street now forecasts 7.17% EPS growth.

The well-informed person Alexandre Conroy who is Executive Vice President of Becton Dickinson & Co sold some 20,128 shares of the firm valued at $4,604,079 U.S. Dollars totalled based on $228.7 per share. This is a major transaction, and one that is unlikely to remain hidden, as it decreased his ownership of the company to 0.01% total market cap, for a total of 29,785 shares. The company’s shares were sold on 23-05-2018 and the report that contains the public information, filed with the U.S. Security & Exchange Commission can be found here.

Another recent and important Becton, Dickinson and Company (NYSE:BDX) news was published by Seekingalpha.com which published an article titled: “Becton, Dickinson: More Than A Short-Term Bounce On The Cards?” on May 10, 2018.

Becton, Dickinson and Company (NYSE:BDX) Institutional Positions Chart